Aardvark Therapeutics, Inc.
AARD
$13.94
$0.382.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.41% | 64.24% | 1,414.27% | 637.44% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,580.59% | 562.47% | -- | 24.60% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 25.98% | -- |
| Total Current Assets | 56.30% | 66.42% | -- | 615.06% | -- |
|
|
|||||
| Total Current Assets | 56.30% | 66.42% | -- | 615.06% | -- |
| Net Property, Plant & Equipment | -47.80% | 397.14% | -- | 374.19% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,444.40% | 1,923.15% | -- | 20,169.23% | -- |
| Total Assets | 59.10% | 69.12% | -- | 635.64% | -- |
|
|
|||||
| Total Accounts Payable | 567.27% | 313.07% | -- | 122.03% | -- |
| Total Accrued Expenses | 261.24% | 263.41% | -- | 874.89% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.82% | 286.11% | -- | 201.79% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 311.03% | 287.16% | -- | 256.51% | -- |
|
|
|||||
| Total Current Liabilities | 311.03% | 287.16% | -- | 256.51% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -78.72% | -- | -- | 782.00% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1,200.00% | -- |
| Total Liabilities | 243.74% | 296.17% | -- | 276.15% | -- |
|
|
|||||
| Common Stock & APIC | 6,438.68% | 7,054.64% | -- | 25.43% | -- |
| Retained Earnings | -98.43% | -80.76% | -- | -54.55% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 365.03% | 423.65% | 532.99% | -57.01% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 188.71% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 188.71% | -- |
|
|
|||||
| Total Common Equity | 365.03% | 423.65% | 532.99% | -57.01% | -- |
| Total Preferred Equity | -- | -- | -- | 188.71% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.87% | 61.97% | 1,555.56% | 692.28% | -- |
|
|
|||||